You are currently browsing the archives for 5 June 2017.
Displaying 1 entry.

CRI relaunches Malignancy Immunity journal The Cancer Research Institute.

This journey was made possible by a grant from Novartis. He will be accompanied by his five children and also Dr. Pellerin, cardiologist Dr. Anique Ducharme and nurses from MHI transplant clinic.. CRI relaunches Malignancy Immunity journal The Cancer Research Institute, Inc. , a U.S. Nonprofit corporation set up in 1953 to progress the discovery and development of safe and effective immunotherapies for cancer, today announced the relaunch of the open access, online journal Malignancy Immunity, the state journal of the Tumor Research Institute. Malignancy Immunity, initial established in 2001, may be the only journal in the field of cancer tumor immunology and immunotherapy focused on open acesss, as well as to providing a broad set of resources and opportunities for interaction and exchange that exceed the traditional scientific journal model to openly and comprehensively facilitate understanding sharing and accelerate study.